Clinical outcomes of hematopoietic stem cell transplantation from HLA-matched parental donor in childhood acute leukemia
![]() |
Cha, Eun Young
(Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Lee, Moon Hee (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Lee, Jae Wook (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Kwon, Young Joo (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Lee, Dae Hyoung (Department of Pediatrics, College of Medicine, Hallym University) Park, Young-Shil (Department of Pediatrics, College of Medicine, Kyung Hee University) Chung, Nak Gyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Jeong, Dae Chul (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Cho, Bin (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Kim, Hack Ki (Department of Pediatrics, College of Medicine, The Catholic University of Korea) |
1 | Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997;15:1767-77 DOI |
2 | Kim HK, Cho B, Chung NG, Jeong DC, Jang PS, Kim SY, et al. Two hundred cases of allogeneic hematopoietic stem cell transplantation in children: single center study. Korean J Hemato Stem Cell Trans 2002;7:63-71 |
3 | Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974;18:295-304 DOI ScienceOn |
4 | Zecca M, Pession A, Messina C, Bonetti F, Favre C, Prete A, et al. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings. J Clin Oncol 1999;17:1838-46 DOI |
5 | Meyers JD. Prevention and treatment of cytomegalovirus infection after marrow transplantation. Bone Marrow Transplant 1988;3:95-104 |
6 | Henslee-Downey PJ, Parrish RS, MacDonald JS, Romond EH, Marciniak E, Coffey C, et al. Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versushost disease following haploidentical marrow transplant. Transplantation 1996;61:738-45 DOI |
7 | Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 2005;65:437-47 DOI ScienceOn |
8 | Hongeng S, Krance RA, Bowman LC, Srivastava DK, Cunningham JM, Horwitz EM, et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997;350:767-71 DOI ScienceOn |
9 | Marks DI, Khattry N, Cummins M, Goulden N, Green A, Harvey J, et al. Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 2006;134:196-201 DOI ScienceOn |
10 | Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, et al. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 2006;24:145-51 DOI ScienceOn |
11 | Petersdorf EW. Risk assessment in haematopoietic stem cell transplantation: histocompatibility. Best Pract Res Clin Haematol 2007;20:155-70 DOI ScienceOn |
12 | Mehta J, Singhal S, Gee AP, Chiang KY, Godder K, Rhee Fv F, et al. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: singlecenter experience of 201 patients. Bone Marrow Transplant 2004;33:389-96 DOI ScienceOn |
13 | Oudshoorn M, Lie JLWT, Bakker JNA, Van Der Zanden HGM, Claas FHJ. Finding the most suitable allogeneic he-matopoietic stem cell donor. In : Atkinson K, Champlin R, Ritz J, Fibbe WE, Ljungman P, Brenner ML, editors. Clinical Bone Marrow And Blood Stem Cell Transplantation. 3rd ed. Cambridge : Cambridge University Press, 2004:369-82 |
14 | Greinix HT, Fae I, Schneider B, Rosenmayr A, Mitterschiffthaler A, Pelzmann B, et al. Impact of HLA class I highresolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant 2005;35:57-62 DOI ScienceOn |
15 | Alonzo TA, Wells RJ, Woods WG, Lange B, Gerbing RB, Buxton AB, et al. Postremission therapy for children with acute myeloid leukemia: the childrens cancer group experience in the transplant era. Leukemia 2005;19:965-70 DOI ScienceOn |
16 | Klingebiel T, Handgretinger R, Lang P, Bader P, Niethammer D. Haploidentical transplantation for acute lymphoblastic leukemia in childhood. Blood Rev 2004;18:181-92 DOI ScienceOn |
17 | Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994;331:1253-8 DOI ScienceOn |
18 | Uderzo C, Rondelli R, Dini G, Dallorso S, Messina C, Miniero R, et al. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study. Br J Haematol 1995;89:790-7 DOI ScienceOn |
19 | Kim HK, Cho B, Chung NG, Jeong DC, Kim SY, Lee HJ, et al. One hundred cases of HLA-matched sibling allogeneic bone marrow transplantation in children : Single center study. J Korean Pediatr Soc 1999;43:402-10 |
20 | Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, et al. Analysis of risk factors for the development of GVHD after T celldepleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow transplant 2001;7:620-30 DOI ScienceOn |
21 | Mrtelli MF, Aversa F, Velardi A, Reisner Y. HLA-mismatched family member hematopoietic stem cell transplantation. In : Atkinson K, Champlin R, Ritz J, Fibbe WE, Ljungman P, Brenner ML, editors. Clinical Bone Marrow And Blood Stem Cell Transplantation. 3rd ed. Cambridge : Cambridge University Press, 2004:1011-26 |
22 | Miller W, Flynn P, McCullough J, Balfour HH Jr, Goldman A, Haake R, et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-vhost disease. Blood 1986;67:1162-7 |
23 | Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004;104:1923-30 DOI ScienceOn |
24 | Chalandon Y, Tiercy JM, Schanz U, Gungor T, Seger R, Halter J, et al. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplant 2006;37:909-16 DOI ScienceOn |
25 | Woods WG, Neudorf S, Gold S, Sanders J, Buckley JD, Barnard DR, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood 2001;97:56-62 DOI ScienceOn |
26 | Cho EY, Park YS, Lee DH, Park JK, Choi SR, Kim SY, et al. CMV antigenemia following pediatric hematopoietic stem cell transplantation : risk factors and outcomes. Korean J Pediatr 2006;49:173-80 DOI |
![]() |